VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.
Gavalas NG, Tsiatas M, Tsitsilonis O, Politi E, Ioannou K, Ziogas AC, Rodolakis A, Vlahos G, Thomakos N, Haidopoulos D, Terpos E, Antsaklis A, Dimopoulos MA, Bamias A.
Gavalas NG, et al. Among authors: dimopoulos ma.
Br J Cancer. 2012 Nov 20;107(11):1869-75. doi: 10.1038/bjc.2012.468.
Br J Cancer. 2012.
PMID: 23169339
Free PMC article.